Losartan and valsartan are both angiotensin receptor blockers (ARBs) that lower blood pressure by blocking the same receptor in your blood vessels. They work similarly enough that a 12-week head-to-head trial found virtually identical blood pressure reductions: losartan lowered diastolic pressure by 9.9 mmHg and valsartan by 10.1 mmHg, a difference of just 0.2 mmHg. Despite that near-identical performance, the two drugs differ in meaningful ways, from what they’re approved to treat to how your body processes them.
How They Block the Same Receptor Differently
Both drugs block the AT1 receptor, which is the docking point for a hormone that tightens blood vessels and raises blood pressure. But they don’t attach to that receptor in exactly the same way. Valsartan binds with moderate affinity and interacts with a broader set of binding sites on the receptor than losartan does. Losartan, by contrast, has the lowest binding affinity among major ARBs and connects at fewer points on the receptor.
This difference matters less than it sounds, because losartan has a trick up its sleeve. Your liver converts losartan into an active metabolite that is 10 to 20 times more potent than losartan itself and lasts much longer in the body. Most of losartan’s blood pressure lowering effect actually comes from this metabolite rather than the original drug. Valsartan doesn’t rely on conversion in the same way; it works directly as the compound you swallow.
Different FDA-Approved Uses
This is one of the biggest practical differences between the two. Losartan is approved for high blood pressure, reducing stroke risk in people with hypertension and an enlarged heart muscle, and treating kidney disease in people with type 2 diabetes. That last indication, diabetic nephropathy, is not shared by valsartan.
Valsartan, on the other hand, is approved for high blood pressure and heart failure. It can also be prescribed to reduce the risk of death in people who develop heart failure after a heart attack. Losartan does not carry that heart failure indication. So which drug your doctor chooses may depend heavily on what else is going on with your health beyond blood pressure.
How Your Body Processes Each Drug
Losartan has a short half-life of just 1.5 to 2.5 hours, meaning it clears from your system quickly. Its active metabolite sticks around longer, peaking at 3 to 4 hours and lasting 6 to 9 hours, which is what allows the drug’s effect to persist through a full 24-hour dosing period. Valsartan has a longer half-life of roughly 6 hours on its own, without needing a metabolite to extend its action. Both are taken once daily.
The way losartan gets converted to its active form introduces a variable that valsartan doesn’t have. Losartan relies primarily on a liver enzyme called CYP2C9 for that conversion. Some people carry genetic variations that make this enzyme work more slowly, which could reduce how much of the active metabolite they produce. If you’re taking other medications that compete for the same enzyme, that can also affect how well losartan works. Valsartan’s metabolism doesn’t depend on this pathway to the same degree, making it less susceptible to these kinds of interactions.
Losartan’s Uric Acid Effect
One feature unique to losartan among ARBs is that it helps the kidneys excrete uric acid. High uric acid levels are linked to gout, and losartan can lower those levels. A large clinical trial found that higher doses of losartan did reduce the incidence of elevated uric acid, though the study wasn’t large enough to confirm whether this translated into fewer actual gout attacks, possibly because even the lower dose was already providing some protection. Valsartan does not have this uric acid lowering property, which can make losartan a more attractive choice for people who have both high blood pressure and elevated uric acid.
Blood Pressure Lowering: Essentially Equal
In a multicenter, randomized, double-blind trial comparing the two drugs over 12 weeks in people with mild to moderate hypertension, losartan and valsartan performed nearly identically. About 57% of losartan patients and 59% of valsartan patients reached their diastolic blood pressure goal by week 12, a difference that was not statistically significant. The typical adult dose of losartan ranges from 50 to 100 mg once daily, while valsartan is commonly prescribed at 80 to 320 mg once daily, reflecting differences in potency per milligram rather than differences in effectiveness.
Side Effects and Tolerability
Both drugs share a similar side effect profile, which is generally mild. Dizziness is the most commonly reported issue with both, occurring in more than 1 in 100 people. This tends to happen when standing up quickly, especially early in treatment as your body adjusts to lower blood pressure. Both can also cause changes in potassium levels, which in rare cases leads to symptoms like muscle cramps, weakness, or an irregular heartbeat. These are signs to bring to your doctor’s attention.
Because ARBs as a class are well tolerated, the side effect profile rarely drives the choice between losartan and valsartan. The more common reasons for choosing one over the other are the approved indications, the uric acid benefit of losartan, or concerns about drug interactions with losartan’s enzyme-dependent metabolism.
Food and Absorption
Eating a high-fat meal with losartan can slow its absorption and reduce peak blood levels by as much as 75%. However, the total amount of drug your body absorbs over time drops by only about 7%, which is minor enough that no dose adjustment or food restriction is required. The active metabolite’s total absorption decreases by roughly 18% with food. Practically speaking, you can take losartan with or without food and still get effective blood pressure control. Valsartan can similarly be taken regardless of meals.
Choosing Between the Two
For straightforward blood pressure control, losartan and valsartan are interchangeable in terms of effectiveness. The decision usually comes down to a few specific clinical scenarios. If you have heart failure or are recovering from a heart attack, valsartan has the approved indication and the supporting evidence. If you have type 2 diabetes with kidney disease, losartan is the one with the specific approval. If you have elevated uric acid or a history of gout, losartan’s uricosuric effect gives it an edge. And if you take multiple medications that interact with CYP2C9, valsartan may be the simpler choice because its effectiveness doesn’t hinge on that enzyme pathway.